Home ›
NPI 1164435780
NPI deactivated
1164435780
1164435780 was paid $3.51M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 14% of everything it billed.
33Billing provider info1164435780
33aNPI1164435780
33bProvider type—
28Total paid$3.51M
24GClaims115,568
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,913 | $437K | |
| 2019 | 20,555 | $556K | |
| 2020 | 14,184 | $418K | |
| 2021 | 17,834 | $606K | |
| 2022 | 15,995 | $576K | |
| 2023 | 15,909 | $530K | |
| 2024incomplete | 12,178 | $382K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 8,560 | 8,325 | $493K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 8,286 | 7,998 | $374K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.8% | 3,682 | 3,591 | $308K |
| 92083 | 8.7% | 9,450 | 9,217 | $306K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.2% | 2,951 | 2,876 | $184K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 4.6% | 3,646 | 3,504 | $162K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 4.5% | 2,583 | 2,530 | $158K |
| 92134 | 4.4% | 10,104 | 9,799 | $155K | |
| 92202 | 4.0% | 15,673 | 15,348 | $141K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 3.4% | 1,899 | 1,650 | $121K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.0% | 1,369 | 1,364 | $106K |
| 92226 | 2.9% | 7,644 | 4,244 | $101K |
42 more codes
| 68761 | 2.6% | 2,126 | $91K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 2.5% | 509 | $87K |
| 92133 | 2.2% | 3,980 | $78K | |
| 92225 | 2.1% | 4,166 | $75K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 2,216 | $72K |
| 92020 | 1.9% | 5,703 | $67K | |
| 93886 | 1.4% | 1,428 | $50K | |
| 93892 | 1.3% | 1,419 | $45K | |
| 93890 | 1.2% | 1,420 | $41K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.1% | 1,333 | $40K |
| 92250 | <1% | 1,200 | $30K | |
| 92002 | <1% | 505 | $30K | |
| 92060 | <1% | 520 | $24K | |
| 92286 | <1% | 1,191 | $24K | |
| 92285 | <1% | 1,464 | $21K | |
| 92136 | <1% | 1,148 | $21K | |
| 92273 | <1% | 356 | $13K | |
| V2020 | Frames, purchases | <1% | 1,674 | $10K |
| 92201 | <1% | 633 | $8K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 14 | $7K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 139 | $7K |
| 66982 | <1% | 41 | $7K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 897 | $6K |
| 92235 | <1% | 161 | $6K | |
| 76512 | <1% | 246 | $6K | |
| 76514 | <1% | 1,119 | $6K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 754 | $5K |
| S0620 | Routine ophthalmological examination including refraction; new patient | <1% | 254 | $5K |
| 66761 | <1% | 40 | $4K | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 262 | $3K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 1,156 | $2K |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 66 | $2K |
| 92145 | <1% | 183 | $2K | |
| 92015 | Determination of refractive state | <1% | 400 | $946.42 |
| 99441 | <1% | 30 | $796.33 | |
| 92025 | <1% | 25 | $503.86 | |
| 83861 | <1% | 95 | $330.46 | |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | <1% | 20 | $190.32 |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 35 | $90.41 |
| 99072 | <1% | 332 | $35.00 | |
| 99080 | 0% | 406 | $0.00 | |
| A4262 | Temporary, absorbable lacrimal duct implant, each | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.